Duchenne muscular dystrophy (DMD) skeletal muscle is characterized by dysregulated calcium handling[41, 42] and impaired mitochondrial bioenergetics.[43, 44] Therefore, we next tested whether CYTOR exon 2 RNA delivery could modify these key DMD disease characteristics. The gene discussed is CYTOR; the disease is Duchenne muscular dystrophy.